Methods of treating using hormone-albumin fusion proteins

US7833521B2 · kind B2 · utility

Assignee

• NOVOZYMES BIOPHARMA DK A/S · DK

Inventors

• Reinhard Fleer · Les Ulis, FR
• Alain Fournier · ᐙᔂᓂᐲ Waswanipi, CA
• Jean-Dominique Guitton · Paris, FR
• Gerard Jung · Montlhéry, FR
• Patrice Yeh · Paris, FR

Key dates

• Filing date: Oct 29, 2007
• Grant date: Nov 16, 2010
• Expiry date: Feb 6, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2319/33
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant of human serum albumin, methods for preparation, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing fusion polypeptides.